Pharmaron Beijing Co (HKSE:03759) Accounts Payable : HK$535 Mil (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Pharmaron Beijing Co Accounts Payable?

Pharmaron Beijing Co's Accounts Payable for the quarter that ended in Sep. 2024 was HK$535 Mil.

Pharmaron Beijing Co's quarterly Accounts Payable increased from Mar. 2024 (HK$418 Mil) to Jun. 2024 (HK$542 Mil) but then declined from Jun. 2024 (HK$542 Mil) to Sep. 2024 (HK$535 Mil).

Pharmaron Beijing Co's annual Accounts Payable increased from Dec. 2021 (HK$386 Mil) to Dec. 2022 (HK$454 Mil) but then declined from Dec. 2022 (HK$454 Mil) to Dec. 2023 (HK$451 Mil).

Pharmaron Beijing Co Accounts Payable Historical Data

The historical data trend for Pharmaron Beijing Co's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaron Beijing Co Accounts Payable Chart

Pharmaron Beijing Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

131.28

227.01

386.36

453.78

450.88

Pharmaron Beijing Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Accounts Payable	Get a 7-Day Free Trial															430.08	450.88	418.32	541.55	534.65

Pharmaron Beijing Co Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Pharmaron Beijing Co Accounts Payable Related Terms

Thank you for viewing the detailed overview of Pharmaron Beijing Co's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmaron Beijing Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaron Beijing Co Ltd (HKSE:03759) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

17Q1:Germany 300759:China

Address

No. 248 Queen’s Road East, 40th Floor, Dah Sing Financial Centre, Wanchai, Hong Kong, HKG

Website

https://www.pharmaron.com

Pharmaron Beijing Co Ltd is a research and development service company supporting the life science industry. The company offers drug research and development service capabilities, ranging from synthetic, medicinal, and analytical chemistry, biology, DMPK, pharmacology, drug safety assessment, radiochemistry and isotopically labelled metabolism, chemical and pharmaceutical development to clinical development. The company's operating segment includes Laboratory services; CMC (small molecule CDMO) services; Clinical development services and biologics and CGT services. It generates maximum revenue from the Laboratory services segment.

Executives

Morgan Stanley	2201 Interest of corporation controlled by you
Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
The Bank Of New York Mellon Corporation	2201 Interest of corporation controlled by you
Citigroup Inc.	2201 Interest of corporation controlled by you
Blackrock, Inc.	2201 Interest of corporation controlled by you
Gic Private Limited	2102 Investment manager
The Capital Group Companies, Inc.	2201 Interest of corporation controlled by you
Matthews International Capital Management, Llc	2102 Investment manager
First H Share Award And Scheme Of Pharmaron Beijing Co., Ltd.	2301 Trustee
Kastle Limited	2301 Trustee
Jian Xin Bei Jing Tou Zi Ji Jin Guan Li You Xian Ze Ren Gong Si	2201 Interest of corporation controlled by you
Jian Xin Xin Tuo You Xian Ze Ren Gong Si	2201 Interest of corporation controlled by you

Pharmaron Beijing Co Headlines

No Headlines